Search - tctmd.com

Displaying 121 - 140 of 194

Sort: Relevancy | Date

News Daily News

FDA Gives Rivaroxaban Another VTE-Related Indication

Todd Neale

October 14, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for August 2019

Shelley Wood

August 30, 2019

News Daily News

FDA Approves Baroreflex Activation Therapy Device for Advanced Heart Failure

Todd Neale

August 19, 2019

News Daily News

FDA Expands TAVR Indication to Low-Risk Patients

Michael O'Riordan

August 16, 2019

News Daily News

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

Shelley Wood

July 16, 2019

News Daily News

FDA Approves Dalteparin Sodium as First Anticoagulant For Use in Pediatric VTE Patients

Yael L. Maxwell

May 16, 2019

News Daily News

Vici Venous Stent Receives FDA Approval for Iliofemoral Obstructive Disease

L.A. McKeown

May 06, 2019

News Daily News

Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy

Michael O'Riordan

May 06, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2019

Shelley Wood

May 01, 2019

News Daily News

PCSK9 Inhibitor Alirocumab Receives Expanded Indication for CV Event Reduction

Michael O'Riordan

April 29, 2019

News Daily News

FDA Grants Approval to TherOx for Supersaturated Oxygen Therapy in LAD STEMI

L.A. McKeown

April 04, 2019

News Daily News

FDA Extends MitraClip Indication to Include Functional MR

Shelley Wood

March 14, 2019

News Daily News

FDA Approves Orsiro Ultrathin-Strut Stent for CAD

Michael O'Riordan

February 22, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2019

Caitlin E. Cox

January 31, 2019

News Daily News

FDA Approves Pea-Sized Occluder for Patent Ductus Arteriosus in Premature Babies

L.A. McKeown

January 14, 2019

News Daily News

European Regulators Strike Secondary Prevention Claim for Omega-3 Drugs

Shelley Wood

December 18, 2018

News Daily News

FDA Advisors Give Blessing to Implantable Pulse Generator in Certain Heart Failure Patients

Yael L. Maxwell

December 05, 2018

News Daily News

Diabetes Drug Canagliflozin Gets MACE Reduction Indication

Todd Neale

November 01, 2018

News Daily News

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

Michael O'Riordan

November 01, 2018

News Daily News

FDA Approves HeartMate 3 as Destination Therapy in Advanced HF

Michael O'Riordan

October 19, 2018

Advertisement

FDA Gives Rivaroxaban Another VTE-Related Indication

TCTMD’s Top 10 Most Popular Stories for August 2019

FDA Approves Baroreflex Activation Therapy Device for Advanced Heart Failure

FDA Expands TAVR Indication to Low-Risk Patients

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

FDA Approves Dalteparin Sodium as First Anticoagulant For Use in Pediatric VTE Patients

Vici Venous Stent Receives FDA Approval for Iliofemoral Obstructive Disease

Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy

TCTMD’s Top 10 Most Popular Stories for April 2019

PCSK9 Inhibitor Alirocumab Receives Expanded Indication for CV Event Reduction

FDA Grants Approval to TherOx for Supersaturated Oxygen Therapy in LAD STEMI

FDA Extends MitraClip Indication to Include Functional MR

FDA Approves Orsiro Ultrathin-Strut Stent for CAD

TCTMD’s Top 10 Most Popular Stories for January 2019

FDA Approves Pea-Sized Occluder for Patent Ductus Arteriosus in Premature Babies

European Regulators Strike Secondary Prevention Claim for Omega-3 Drugs

FDA Advisors Give Blessing to Implantable Pulse Generator in Certain Heart Failure Patients

Diabetes Drug Canagliflozin Gets MACE Reduction Indication

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

FDA Approves HeartMate 3 as Destination Therapy in Advanced HF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content